Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Mimedx Group Inc (MDXG)

Mimedx Group Inc (MDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
MIMEDX to Participate in Upcoming Investor Conferences GlobeNewswire - Mon Nov 4, 7:00AM CST

MDXG : 7.47 (+0.13%)
MiMedx: Q3 Earnings Snapshot AP - Wed Oct 30, 3:26PM CDT

MiMedx: Q3 Earnings Snapshot

MDXG : 7.47 (+0.13%)
MIMEDX Announces Third Quarter 2024 Operating and Financial Results GlobeNewswire - Wed Oct 30, 3:01PM CDT

MDXG : 7.47 (+0.13%)
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 GlobeNewswire - Mon Oct 14, 7:00AM CDT

MDXG : 7.47 (+0.13%)
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue GlobeNewswire - Tue Oct 8, 3:01PM CDT

MDXG : 7.47 (+0.13%)
MiMedx: Q2 Earnings Snapshot AP - Wed Jul 31, 3:22PM CDT

MiMedx: Q2 Earnings Snapshot

MDXG : 7.47 (+0.13%)
MiMedx Group (NASDAQ: MDXG) Reports Q1 2023 Financial Results Showing 21.7% Sales Growth Spotlight Growth - Wed May 3, 2023

MiMedx Group, Inc. (NASDAQ: MDXG) is engaged as a biotechnology company that is focused as a placental biologics developer to

MDXG : 7.47 (+0.13%)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 FinancialNewsMedia - Tue Nov 15, 2022

EQNX::TICKER_START (OTCQB:OCEL),(NASDAQ:BRTX),(NASDAQ:MDXG),(NYSE:NNVC),(NASDAQ:VCEL) EQNX::TICKER_END

VCEL : 55.47 (-0.75%)
OCEL : 2.7500 (unch)
BRTX : 1.5400 (-6.10%)
MDXG : 7.47 (+0.13%)
NNVC : 1.3500 (unch)
Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 PR Newswire - Tue Nov 15, 2022

/PRNewswire/ -- Chronic obstructive pulmonary disease is a chronic lung disease that prevents airflow from the lungs. The rising incidence of COPD is one...

OCEL : 2.7500 (unch)
BRTX : 1.5400 (-6.10%)
MDXG : 7.47 (+0.13%)
NNVC : 1.3500 (unch)
VCEL : 55.47 (-0.75%)
MIMEDX to Present at the Canaccord Genuity 42nd Annual Growth Conference Globe Newswire - Thu Aug 4, 2022

MARIETTA, Ga., Aug. 04, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics...

MDXG : 7.47 (+0.13%)

Barchart Exclusives

3 Dividend Stocks to Scoop Up Now for a Strong 2025 Barchart - Wed Nov 13, 6:30PM CST
With Donald Trump's return to the White House, the transportation industry could be set for big changes, and three dividend-paying stocks - J.B. Hunt, Knight-Swift, and CSX - are well-positioned to benefit from increased demand for shipping containers and freight services. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot